Society ❯ Ethics ❯ Reproductive Rights

Abortion

Public Opinion Mifepristone Legal Challenges Mifepristone Safety Reproductive Health Services Assisted Dying Public Funding Legal Status Funding Restrictions Chemical Abortion Public Health Anti-Abortion Activism Abortion Laws Conscience Freedom Healthcare Access

Hawley Pressures FDA Chief as Anti‑Abortion Groups Demand Firing Over Reported Mifepristone Review Delay

The FDA describes an evidence‑driven study now in a data‑gathering phase with no projected timeline.

FDA Confirms Safety Review of Mifepristone With No Regulatory Changes Yet

FDA Approves Second Generic Mifepristone as White House Cites Legal Obligation

Blog Jobs Terms of Service Privacy Policy Cookies Help Partners About Us Copyright © 2026 Mina Labs, Inc.

We value your privacy

We and our partners use cookies and similar technologies to understand how you use our site and to show you personalized advertisements on other platforms. By clicking "Accept All," you consent to these technologies for advertising, analytics and retargeting. Click "Decline All" to opt out of non-essential cookies. You can learn more in our Privacy Policy.